Interventional spine tech: Revolutionary or all hype?

Spinal Tech

At the 20th Annual Spine, Orthopedic + Pain Management-Driven ASC Conference, attendees gathered to explore the powerful topic of interventional spine technology.

This dynamic panel was composed of four experts in the field, moderated by Riz Hatton, Assistant Editor of Becker's Healthcare.

- Mick Perez-Cruet, MD, MSc, Professor and Vice Chair, Department of Neurosurgery, Oakland University William Beaumont School of Medicine
- Vivek Mohan, MD, MS, Spine Surgeon, Orthopaedic Spine Institute
- Moody Makar, MD, Anesthesiologist, Cedars - Sinai Medical Center
- Akshat Gargya, MD, FIPP, Assistant Professor of Anesthesiology and Pain Medicine, Attending Anesthesiologist and Interventional Pain Physician, University of Vermont Medical Center

Each panelist brought their unique perspective to the discussion of the revolutionary and ever-evolving field of Interventional spine tech.

Key Takeaways:

  • The most revolutionary interventional spine technologies are stem cell based disc regeneration and minimally invasive spine surgery to preserve spine anatomy and stop spinal stenosis.

The panelists mentioned stem cell-based disc regeneration and minimally invasive spine surgery as the most innovative technologies with potential to help patients. Stem cell therapy has shown promise in regenerating damaged spinal discs leading to relief from chronic back pain. Minimally invasive spine surgery is a technique where small incisions are made to reduce blood loss, minimize pain, and accelerate the healing process.

  • Investing in interventional spine technologies should involve understanding real-time market data, quarterly financial statements, diversification of companies, and being critical of hype.

The panelists highlighted that investing in interventional spine technologies involves understanding real-time market data, quarterly financial statements, diversification of companies, and being careful not to believe all the hype around certain technologies or companies. Doing thorough research before investing in a company that claims to have a breakthrough technology can save investors from potential failures.

  • Being patient-centric is key when treating patients with pain and functional deficits, and preserving normal anatomy is crucial.

The panelists emphasized the importance of being patient-centric when treating patients with pain and functional deficits and preserving normal anatomy. This means that physicians should consider multiple sources of data before determining the best course of treatment that would preserve the patient's normal anatomy as much as possible.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Articles We Think You'll Like

 

Featured Webinars

Featured Whitepapers